MLchartDataset catalogue

Alvocidib

Term · Oncology and biomedicine · MLC-T-ONC-000429

A substance being studied in the treatment of several types of cancer. It stops cells from dividing and may kill cancer cells. It is a type of cyclin-dependent kinase (CDK) inhibitor. Also called flavopiridol and HMR 1275.

Table 1. Record
IdentifierMLC-T-ONC-000429
FieldOncology and biomedicine
Synonymsflavopiridol; HMR 1275
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-000429",
  "term": "Alvocidib",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of several types of cancer. It stops cells from dividing and may kill cancer cells. It is a type of cyclin-dependent kinase (CDK) inhibitor. Also called flavopiridol and HMR 1275.",
  "synonyms": [
    "flavopiridol",
    "HMR 1275"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/alvocidib/"
}

Record 931 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.